Firm Blog

Plans Launched for Largest Research Study on Breast Cancer in African-American Women

According to an article on boston.com, the largest study to-date on breast cancer in African-American women will be conducted by a team of researchers at the Slone Epidemiology Center at Boston University. The University has received almost $20 million from the National Cancer Institute (NCI) to evaluate why African-American women are reported to have higher rates
Read More

Ongoing FDA Safety Review Reveals Increased Risk of Bladder Cancer for Actos Users

According to the American Diabetes Association, millions of people have been diagnosed with type 2 diabetes in the U.S. Actos, or pioglitazone, is manufactured by the Takeda Pharmaceutical Company and is used to help regulate blood sugar in adults with type 2 diabetes mellitus. Based on data provided by the U.S. Food and Drug Administration (FDA), from
Read More

National Down Syndrome Congress Annual Convention Welcomed New Jersey Participants

The 39th Annual National Down Syndrome Congress (NDSC) Convention was held August 5-7, 2011 in San Antonio, Texas. Thousands of individuals from throughout the United States attended the convention to learn more about the latest information and research on Down Syndrome. One person attending the conference described it as inspiring and exhilarating. It was noted
Read More

Toms River Oncologist Loses Medical License Following Hepatitis B Outbreak

After a medical license suspension of over two years, the New Jersey Board of Medical Examiners revoked the license of Dr. Parvez Dara for a total of four years and fined him $30,000 in civil penalties due to “gross and repeated acts of negligence,” according to NJ.com. Because his license had already been suspended, however, he
Read More